EGFR Mutations in Head and Neck Squamous Cell Carcinoma

EGFR is a prototypical receptor tyrosine kinase that is overexpressed in multiple cancers including head and neck squamous cell carcinoma (HNSCC). The standard of care for HNSCC remains largely unchanged despite decades of research. While EGFR blockade is an attractive target in HNSCC patients and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Sindhu, Bonner, James A., Bredel, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999014/
https://www.ncbi.nlm.nih.gov/pubmed/35409179
http://dx.doi.org/10.3390/ijms23073818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999014/
https://www.ncbi.nlm.nih.gov/pubmed/35409179
http://dx.doi.org/10.3390/ijms23073818

Ejemplares similares